Workshop 4: Il late-presenter Moderatori: G. Ippolito, M. Moroni Discussant: R. Iardino Limportanza della risposta immunologica S. Rusconi.

Slides:

Advertisements

Similar presentations

From "3 by 5" to Universal Access

Advertisements

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500.

Cardiovascular Side Effects of HIV Treatment

HIV TB. World wide TB is the most common cause of death in people with HIV About 1/3 of HIV infected people worldwide are co-infected with TB (co-infection.

ThemeGallery PowerTemplate

Name: Date: Read temperatures on a thermometer Independent / Some adult support / A lot of adult support

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

Workshop 4: Il late-presenter Moderatori: G. Ippolito, M. Moroni Discussant: R. Iardino Quando cominciare: Impatto delle comorbidità A. Cingolani.

Workshop 4: Il late-presenter Moderatori: G. Ippolito, M. Moroni Discussant: R. Iardino Risposta virologico-clinica e scelta della terapia C. Mussini.

Workshop 5: Il coinfetto Moderatori: G. Angarano, V. Vullo Discussant: A. Cerioli Quando e come cominciare P. Nasta.

Workshop 4: “Il late-presenter”

Demonstration Problem

$100 $400 $300$200$400 $200$100$100$400 $200$200$500 $500$300 $200$500 $100$300$100$300 $500$300$400$400$500.

St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?

TB and HIV Management Dr A.L. Pozniak Chelsea and Westminster Hospital London, UK.

New Paradigms in the management of HIV/HCV co- infected patients Sanjay Bhagani Royal Free Hospital London.

TABLE OF CONTENTS CHAPTER 5.0: Workforce

Chapter 5: Workforce. Chartbook 2003 Physician Workforce After dropping slightly in 1999, the number of active physicians per thousand population rose.

AIDS epidemic update Figure AIDS epidemic update Figure 2007 Estimated adult (15–49 years) HIV prevalence rate (%) globally and in Sub-Saharan Africa,

AIDS epidemic update Figure AIDS epidemic update Figure 2007 Estimated adult (15–49 years) HIV prevalence rate (%) globally and in Sub-Saharan Africa,

How Dewey Do Dewey??? Dewey Decimal Classification System Kathy Smith.

Category Category Category Category Category.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

How Much Money Do I Need To Make?. Monthly Budget.

1 The Backlog Issue and the JPO's Effort Koichi Minami Deputy Commissioner Japan Patent Office.

Malaria Figures 3.3 billion people at risk of malaria in billion at high risk (>1 case/1000 population) mainly in the WHO African (49%) and South.

WHO WANTS TO BE A MILLIONAIRE? CAPACITY STYLE.

Who Wants To Be A Millionaire?

Who Wants To Be A Millionaire? Mrs Mances Edition.

Who Wants To Be A Millionaire? Year 3 What does it weigh?

Roman Numerals.

Can you explain the ideas

I can interpret intervals on partially numbered scales and record readings accurately ? 15 ? 45 ? 25 ? 37 ? 53 ? 64 Each little mark.

From 3by5 to Universal Access – lessons learned and new challenges ODI Meetings Series Do big plans help big numbers? 7 th June 2006 Prof Charlie Gilks.

£1 Million £500,000 £250,000 £125,000 £64,000 £32,000 £16,000 £8,000 £4,000 £2,000 £1,000 £500 £300 £200 £100 Welcome.

Miriam Lichtner Dipartimento di Malattie Infettive e Sanità Pubblica Sapienza Università di Roma Polo Pontino Componente dell Italian National Focal Point.

How Universal will Universal Access be in Europe by 2010? Eddy Beck Evaluation Department UNAIDS, Geneva

HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the UK – 30 years on… Since 1981: 122,000 HIV diagnoses.

Phases of HIV/AIDS 1. Infection 2. Window period 3. Seroconversion 4. Asymptomatic period 5. HIV/AIDS - related illness 6. AIDS.

Sl No Top-up Amount No Of Affiliate Ads Payment Per Day By Affiliate Ad Total Affiliate Ad Income 1.5,000/- Daily 2 ad for 100 days 100/- Affiliate.

Antiretroviral Therapy: An HIV Prevention Strategy? Wafaa El-Sadr, MD, MPH Columbia University Harlem Hospital New York.

Reading Scale (1) (Mental Maths)

Clinical Care: 2010 Institute of Medicine Committee on HIV Screening and Access to Care Michael Saag, MD, FIDSA University of Alabama, Birmingham Director,

UNAIDS – Children and HIV in Jamaica and the Caribbean region

Category Category 2Category 3Category 4Category

$ TOTAL INCOME 100 Quick Start 4 Within 30 Days of Start Date.

Making Landmark or Friendly Numbers (Multiplication)

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

Category Heading Category Heading Category Heading.

Unit 2 Lesson 8 Part 1: Rounding to the Nearest Thousand Copyright © 2009 Kelly Mott.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

10 Year Old Topic 2 9 Year Old Topic 4 8 Year Old Topic 5 8 Year Old Topic 6 7 Year Old Topic 7 7 Year Old Topic 8 6 Year Old Topic 9 6 Year Old Topic.

Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director, BC-Centre for Excellence in HIV/AIDS at Providence.

HIV i-Base: Training for Advocates, 10/2004www.i-Base.info Section 1&2: CD4 and Viral Load Reduced slide set HIV i-Base STEP EATG HIV Training for Advocates.

HYPnet Late presentation of vertically transmitted HIV infection in adolescence A Judd 1, R Ferrand 2,3, E Jungmann 2, C Foster 4, H Lyall 4, Brian Rice.

Equal or Not. Equal or Not

Blank Jeopardy. Category #1 Category #2 Category #3 Category #4 Category #

Partial Products. Category 1 1 x 3-digit problems.

8 th RD50 Workshop Prague June Università degli Studi Università degli Studi di Perugia di Perugia 1 Annealing effects on p + n junction 4H-SiC.

HIV and Aging Kathleen K Casey, MD Director, AIDS Ambulatory Care Center Jersey Shore University Medical Center.

HIV/AIDS DEPARTMENT 2013 Consolidated ARV Guidelines Treatment Recommendations for Pregnant and Breastfeeding Women: Critical Issues Dr. Nathan Shaffer.

HIV Early Treatment Project Groups 1 and 2 n Among HIV-infected participants in sub-Saharan Africa, does initiation of antiretroviral treatment (ART) at.

Presentation transcript:

Workshop 4: Il late-presenter Moderatori: G. Ippolito, M. Moroni Discussant: R. Iardino Limportanza della risposta immunologica S. Rusconi

Il late-presenter: limportanza della risposta immunologica Roma, preIAS journey - ISS 16 dicembre 2010 Stefano Rusconi DISC L.Sacco, Sezione di Malattie Infettive e Immunopatologia Università degli Studi di Milano

CD4 count at start of HAART, Egger M, et al. CROI Abstract 62. Data from 42 countries, 176 sites; n=33,008 Since 2000, CD4+ cell count at initiation has increased in Sub-Saharan Africa from 50 to 100 cells/mm 3 ; in developed countries it has remained 150–200 cells/mm 3

Numero CD4 alla diagnosi

Prognosis from starting ART according to pre- therapy CD4 cell counts (cells/µL) ART CC. Egger et al, Lancet Probability of AIDS or Death (%) Years From Starting ART >

CASCADE: Nadir CD4+ Cell Count Predicts AIDS and Non-AIDS Events Marin B, et al. IAS Abstract WEPEB Nadir CD4+ cell count AIDS-Related Death vs vs 350 < 50 vs 350 Non-AIDS–Related Death Non-AIDS Cancer Death Liver Disease Death vs vs 350 < 50 vs vs vs 350 < 50 vs vs vs 350 < 50 vs 350 CASCADE Collaboration cohort: N = 9858 Several clinical markers of HIV progression correlated with death due to AIDS-related causes, non-AIDS–related severe infection, liver diseases, and non-AIDS–related malignancies including – Latest and nadir CD4+ cell counts – Time spent with CD4+ cell count < 350 cells/mm 3

Gras L, et al. J Acquir Immun Defic Syndr. 2007;45: CD4 Cell Count (cells/mm 3 ) Week >500 (n=389) 350 – 500 (n=694) 200 – 350 (n=1,513) 50 – 200 (n=1,773) <50 (n=930) Baseline CD4 (cells/mm 3 ) 50% of those with CD4 nadir <200 fail to reach 500 after 7 years VL suppression. Suboptimal CD4 T Cell Gains Are Common Among Patients Who Initiate HAART Late (ATHENA)

CNICS: 40% of patients with a nadir CD4 < 200 fail to achieve a normal CD4+ cell count, even after 10 years of viral suppression (n=300) Kelley CF, et al. Clin Infect Dis 2009;48: < >350 Nadir CD4 Year of HAART CD4+ T Cell > 500 cells/mm 3 (%)

Influence of Age on CD4 Cell recovery

e la qualità dei CD4…? C. Negri, S. Rusconi, A. Gori et al. AIDS, Dec. 1996, 10:

More MVC Recipients Exceeded Clinically Relevant CD4 + Thresholds in MERIT MVC (N = 123) EFV (N = 104) Percentage of Patients 200 Cells/µL 350 Cells/µL 500 Cells/µL CD4 + Count at Week 96 Patients with Baseline CD4 + Counts < 200 Cells/ L n= Lazzarin A, et al. HIV10, Glasgow 2010, O422

Conclusion LPV/r monotherapy failures occurred in first 24 weeks High failure rate was associated with low nadir CD4+ cell count (CD4+ <200 cells/mL) Kaplan-Meier analysis of failure by CD4+ count Gutman C, et al. 16 th CROI, Montreal 2009, # % without failure CD4+ Nadir <200 CD4+ Nadir >200 weeks LPV/r monotherapy failures associated with low nadir CD4+ (MOST Study)